Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us
Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us
Corporate Documents
2021 Placing and Open Offer shareholder circular
steve
|
2 February 2021
2021 Placing form of proxy
steve
|
2 February 2021
AIM Admission Document
steve
|
15 October 2015
Articles of Association
steve
|
12 October 2015
Capital Access – Ox-1 10kg toxicology study quantity achieved
mel
|
5 January 2026
Capital Access Group – DAT asset potential value highlighted
mel
|
18 December 2025
Capital Access Group – Orexin M&A demonstrates industry appetite
mel
|
13 April 2026
Capital Access Group – Ox-1 Imminent start of final toxicology study
mel
|
23 March 2026
Capital Access Group – Ox-1/DAT programmes – indicative proposal
mel
|
14 April 2026
Capital Access Group – Patent protection potentially extending to 2046
mel
|
16 April 2026
Capital Access Group – Research Note on Full Year Results
mel
|
3 June 2025
Capital Access Group – Research Note on Half-Year Results
mel
|
3 December 2025
Posts navigation
←
older
